PREVICOX 227 MG VETERINARY

Valsts: Izraēla

Valoda: angļu

Klimata pārmaiņas: Ministry of Health

Nopērc to tagad

Lejuplādēt Lietošanas instrukcija (PIL)
20-12-2021
Lejuplādēt Produkta apraksts (SPC)
20-12-2021

Aktīvā sastāvdaļa:

FIROCOXIB

Pieejams no:

BEIT-EREZ HAVAT MILATIN LTD

Zāļu forma:

CHEWABLE TABLETS

Kompozīcija:

FIROCOXIB 227 MG

Ievadīšanas:

PER OS

Receptes veids:

Required

Ražojis:

BOEHRINGER INGELHEIM VETMEDICA GMBH, GERMANY

Ārstēšanas norādes:

For the relief of pain and inflammation associated with osteoarthritis in dogs.For the relief of post-operative pain and inflammation associated with soft-tissue surgery in dogs.For the relief of post-operative pain and inflammation associated with orthopaedic and dental surgery in dogs.

Autorizācija datums:

2015-10-31

Lietošanas instrukcija

                                وأ ىقلتي بلكلا ناك اذإ :تلاعافتلا نم
ىرخأ عاونأو ،ىرخلأا ةيودلأا عم
تلاعافتلا
وأ يرطيبلا بيبطلا غلابإ كيلع ،ىرخأ
تارضحتسمو ىرخأ ةيودأ ا
ً
رخؤم ىقلت اذإ
.ىرخلأا ةيودلأا عم تلاعافتلا نع
ةجتانلا ةعجانلا مدع وأ رطاخملا بنجتل
يلديصلا
تاديوريتس :ىقلتي بلكلا ناك اذإ صاخ
لكشب يلديصلا وأ يرطيبلا بيبطلا غلابإ
كيلع
ذنم لقلأا ىلع ةعاس 24 راظتنلااب ىصوي(
باهتللال ةداضم ىرخأ تارضحتسمو
ىلكلا/لوبلا زاهج يف رثؤت ةيودأ
،)سكوكيڨيربب جلاعلا ءدب لبقو قباسلا
جلاعلا ءاهتنا
تانيتوربب طبترت ةيودأو ،)ريدختلل
ةيودأ ،ACE ميزنإ تاطبثم ،لوبلا تا
ّ
ردم :لاثم(
ةيودأ اهتفصب ةفورعم ةيودأ ءاطعإ هتاذ
تقولا يف متي نأ نع عانتملاا بجي .مدلا
.ىلكلل ةماس
،نزولا ضافخنا :ىلإ ءاودلا نم ةطرفم
ةعرج ءاطعإ يدؤي دق :ةطرفملا ةعرجلا
ينثلإا يف ةحرق ،غامدلا يف ررض ،)نهدلا
سدكت( دبكلا يف تارييغت ،ةيهشلا نادقف
اذإ .ءاودلا ءاطعإ فقو دعب ساكعنلال
لباق ضارعلأا هذه ضعب .ةافولاو تاؤيقت
،رشع
،اروف ءاودلا ءاطعإ فقو بجي ،ةطرفم ةعرج
ىلع تاملاع/ةملاع بلكلا ىدل ترهظ
.اروف يرطيبلا بيبطلا ةراشتساو
.فورعم ريغ :(
INCOMPATIBILITY ( ةمءلاملا صقن (
:نيزختلا تاميلعت
لوانتم نع ا
ً
ديعب ،قلغم ناكم يف ،رخآ ءاود
ّ
لكو ،ءاودلا اذه ظفح بجي !م
ّ
مستلا ب
ّ
نجت
.م
ّ
مستلا ب
ّ
نجتت اذكهو ،لافطلأا وأ/و دلاولأا ةيؤ
                                
                                Izlasiet visu dokumentu
                                
                            

Produkta apraksts

                                Page 1 of 6
VETERINARY PHYSICIAN’S PRESCRIBING INFORMATION
PREVICOX 57 MG AND 227 MG VETERINARY
1. TRADE NAME OF MEDICINAL PRODUCT
PREVICOX 57 MG VETERINARY
PREVICOX 227 MG VETERINARY
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each chewable tablet contains:
TRADE NAME OF MEDICINAL PRODUCT:
ACTIVE SUBSTANCE:
PREVICOX 57 MG VETERINARY
Firocoxib 57 mg per chewable tablet
PREVICOX 227 MG VETERINARY
Firocoxib 227 mg per chewable tablet
EXCIPIENTS: Iron Oxides (E172) and Caramel (E150d).
For the full list of excipients, see section 6.1
3. PHARMACEUTICAL FORM
Chewable tablets.
Tan-brown, round, convex, tablets with a cross-shaped break line on
one side. The tablets can
be divided into 2 or 4 equal parts.
4. CLINICAL PARTICULARS
4.1 TARGET SPECIES: Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES:
For the relief of pain and inflammation associated with osteoarthritis
in dogs.
For the relief of post-operative pain and inflammation associated with
soft-tissue surgery in
dogs.
For the relief of post-operative pain and inflammation associated with
orthopaedic and dental
surgery in dogs.
4.3 CONTRAINDICATIONS:
Do not use in pregnant or lactating bitches.
Do not use in animals less than 10 weeks of age or less than 3 kg body
weight.
Do not use in animals suffering from gastrointestinal bleeding, blood
dyscrasia or
haemorrhagic disorders.
Do not use concomitantly with corticosteroids or other non-steroidal
anti-inflammatory drugs
(NSAIDs).
4.4 SPECIAL WARNINGS: None.
4.5 SPECIAL PRECAUTIONS FOR USE:
Special precautions for use in animals: The recommended dose, see
section 4.9, should not be
exceeded.
Use in very young animals, or animals with suspected or confirmed
impairment of renal,
cardiac or hepatic function may involve additional risk. If such use
cannot be avoided, those
dogs require careful veterinary monitoring.
Page 2 of 6
Avoid use in dehydrated, hypovolaemic or hypotensive animals, as there
is a potential risk of
increased renal toxicity. Concurrent administration of potentially
nephrotoxic drugs shou
                                
                                Izlasiet visu dokumentu
                                
                            

Dokumenti citās valodās

Lietošanas instrukcija Lietošanas instrukcija arābu 20-12-2021
Lietošanas instrukcija Lietošanas instrukcija ivrits 20-12-2021

Meklēt brīdinājumus, kas saistīti ar šo produktu